Halo Pharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- Halo Pharmaceutical's estimated annual revenue is currently $59.3M per year.
- Halo Pharmaceutical's estimated revenue per employee is $251,250
Employee Data
- Halo Pharmaceutical has 236 Employees.
- Halo Pharmaceutical grew their employee count by 3% last year.
Halo Pharmaceutical's People
Name | Title | Email/Phone |
---|---|---|
1 | Security Officer | Reveal Email/Phone |
2 | Validation Manager | Reveal Email/Phone |
3 | QA Manager | Reveal Email/Phone |
4 | QC Manager | Reveal Email/Phone |
5 | Warehouse Manager | Reveal Email/Phone |
6 | Chef, Supply Chain | Reveal Email/Phone |
7 | Analyste micobiologie | Reveal Email/Phone |
8 | Spécialiste support technique, laboratoire contrôle qualité | Reveal Email/Phone |
9 | Pharmaceutical | Reveal Email/Phone |
10 | Data Reviewer | Reveal Email/Phone |
Halo Pharmaceutical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.6M | 33 | 32% | N/A | N/A |
#2 | $38M | 189 | 6% | N/A | N/A |
#3 | $6.6M | 33 | 22% | N/A | N/A |
#4 | $4180M | 15242 | 1% | $550M | N/A |
#5 | $17.5M | 87 | 50% | N/A | N/A |
#6 | $6.7M | 125 | -37% | $199.6M | N/A |
#7 | $10.9M | 54 | 15% | N/A | N/A |
#8 | $15.3M | 76 | 33% | N/A | N/A |
#9 | $128.6M | 640 | 16% | N/A | N/A |
#10 | $18.7M | 93 | 21% | N/A | N/A |
What Is Halo Pharmaceutical?
Halo Pharmaceutical, headquartered in Whippany, New Jersey contract manufactures product for several clients and is a full service FDA, (both CBER and CDER) and DEA (C2-C5) facility. The manufacturing capabilities cover all aspects of commercial production of small molecule and biological drugs, specializing in solid dosage form manufacturing and finished goods packaging.
keywords:N/AN/A
Total Funding
236
Number of Employees
$59.3M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Halo Pharmaceutical News
The transaction has been unanimously approved by both the Halozyme (NASDAQ: HALO) and Antares boards of directors.
April 13 (Reuters) - Halozyme Therapeutics Inc (HALO. ... all-cash deal for specialty pharmaceutical company Antares Pharma Inc (ATRS.
SAN DIEGO and EWING, N.J., April 13, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") and Antares Pharma,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 243 | 69% | N/A |
#2 | $102.8M | 455 | 7% | N/A |
#3 | $126.8M | 461 | 8% | N/A |
#4 | $107.7M | 594 | N/A | N/A |
#5 | $165.5M | 739 | 7% | N/A |